Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02212210 · ClinicalTrials.gov registry record · Early Phase 1
Maternal Epidural Steroids and Hyperthemia
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 135
- Enrollment target
NCT02212210: Clinical Trial Early Phase 1 study, sponsored by Medical University of South Carolina.
NCT02212210 is a Early Phase 1 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 135 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (155% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02212210, a Early Phase 1 study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 135 participants
- Enrollment target
Study Summary
The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.
Primary Outcome
Oral maternal temperature will be collected hourly starting at epidural placement. Temperature will be recorded until delivery.
Interventions
- DRUG Normal saline
- DRUG Methylprednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-10 |
| Phase | Early Phase 1 |
Why NCT02212210 stopped before completion
NCT02212210 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (155% higher).
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT02212210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02212210 about?
NCT02212210 is a clinical study titled "Maternal Epidural Steroids and Hyperthemia". The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.
What is the current status of trial NCT02212210?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 135 participants. The study started on 2012-02. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02212210?
The interventions under investigation include: Normal saline (DRUG), Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT02212210?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02212210's enrollment target sits among peer trials
135 128th of 2000 higher than 1,871 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia